The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?

PLoS One. 2016 Dec 9;11(12):e0167984. doi: 10.1371/journal.pone.0167984. eCollection 2016.

Abstract

The vast majority of patients with Nijmegen Breakage Syndrome (NBS) are of Slavic origin and carry a deleterious deletion (c.657del5; rs587776650) in the NBN gene on chromosome 8q21. This mutation is essentially confined to Slavic populations and may thus be considered a Slavic founder mutation. Notably, not a single parenthood of a homozygous c.657del5 carrier has been reported to date, while heterozygous carriers do reproduce but have an increased cancer risk. These observations seem to conflict with the considerable carrier frequency of c.657del5 of 0.5% to 1% as observed in different Slavic populations because deleterious mutations would be eliminated quite rapidly by purifying selection. Therefore, we propose that heterozygous c.657del5 carriers have increased reproductive success, i.e., that the mutation confers heterozygote advantage. In fact, in our cohort study of the reproductive history of 24 NBS pedigrees from the Czech Republic, we observed that female carriers gave birth to more children on average than female non-carriers, while no such reproductive differences were observed for males. We also estimate that c.657del5 likely occurred less than 300 generations ago, thus supporting the view that the original mutation predated the historic split and subsequent spread of the 'Slavic people'. We surmise that the higher fertility of female c.657del5 carriers reflects a lower miscarriage rate in these women, thereby reflecting the role of the NBN gene product, nibrin, in the repair of DNA double strand breaks and their processing in immune gene rearrangements, telomere maintenance, and meiotic recombination, akin to the previously described role of the DNA repair genes BRCA1 and BRCA2.

MeSH terms

  • Adult
  • Cell Cycle Proteins / genetics*
  • Cohort Studies
  • Czech Republic
  • DNA Damage
  • DNA Repair
  • Female
  • Founder Effect*
  • Genetic Carrier Screening
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Nijmegen Breakage Syndrome / ethnology
  • Nijmegen Breakage Syndrome / genetics*
  • Nuclear Proteins / genetics*
  • Reproduction / genetics*
  • Slovakia

Substances

  • Cell Cycle Proteins
  • NBN protein, human
  • Nuclear Proteins

Grants and funding

This work was supported by grants from the Sander Stiftung to KS and ES, by grants from the DFG to AR, KS and MD, by the German Ministry of Education and Research (BMBF) through National Genome Research Network (NGFN) grants to MK and MN, by grant 108-1081870-1885 of the Ministry of Science, Education and Sport of the Republic of Croatia to IB, and by grants AZV 12-31899 A and DRO 00064203 from the Czech Ministry of Health to PS. The Sorb study was supported by Federal Ministry of Education and Research (BMBF), Germany, (FKZ: 01EO1501) and by grants from the Collaborative Research Center funded by the German Research Foundation (CRC 1052; C01, B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.